Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2005 Mar;3(2):99-102.
doi: 10.3736/jcim20050205.

[Ginsenosides Combined With Dexamethasone in Preventing and Treating Postembolization Syndrome Following Transcatheter Arterial Chemoembolization: A Randomized, Controlled and Double-Blinded Prospective Trial]

[Article in Chinese]
Affiliations
Randomized Controlled Trial

[Ginsenosides Combined With Dexamethasone in Preventing and Treating Postembolization Syndrome Following Transcatheter Arterial Chemoembolization: A Randomized, Controlled and Double-Blinded Prospective Trial]

[Article in Chinese]
Ying-Lu Feng et al. Zhong Xi Yi Jie He Xue Bao. .

Abstract

Objective: To observe the effect of ginsenosides (GS) and low dose glucocorticoid in preventing and treating the postembolization syndrome following transcatheter arterial chemoembolization (TACE).

Methods: Eighty patients with primary liver carcinoma were randomly divided into 4 double-blinded groups, with 20 patients in each group. Patients in groups A, B, C, D were treated with placebo, dexamethasone (Dex), GS, Dex and GS, respectively. The changes of clinical symptoms and laboratory tests after TACE were observed.

Results: Dex combined with GS markedly decreased the occurrence ratio and lasting time of the symptoms such as nausea, vomiting, fever and pain, and protected the function of liver as compared with the placebo (P<0.05). Single use of Dex or GS improved some symptoms as compared with the placebo, but it was not as good as the combination of Dex and GS.

Conclusion: Dex combined with GS can effectively prevent and treat the postembolization syndrome following TACE.

Similar articles

See all similar articles

Publication types

MeSH terms

Feedback